Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-22 8:35 pm Purchase | 13G | ANNEXON INC ANNX | BB BIOTECH AG | 4,682,290 5.2% | 4,682,290 (New Position) | View |
| 2024-02-14 8:46 pm Sale | 13G | ANNEXON INC ANNX | Venrock Healthcare Capital Partners II L.P. | 968,679 1.2% | -3,960,321 (-80.35%) | View |
| 2024-02-14 4:58 pm Sale | 13G | ANNEXON INC ANNX | CITADEL ADVISORS LLC | 1,069,087 1.4% | -1,431,220 (-57.24%) | View |
| 2024-02-14 4:26 pm Purchase | 13G | ANNEXON INC ANNX | Redmile Group LLC | 8,083,776 9.9% | 3,186,201 (+65.06%) | View |
| 2024-02-14 3:45 pm Sale | 13G | ANNEXON INC ANNX | Fairmount Funds Management LLC | 322,893 0.4% | -3,358,563 (-91.23%) | View |
| 2024-02-14 12:43 pm Sale | 13G | ANNEXON INC ANNX | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -3,626,508 (Position Closed) | View |
| 2024-02-14 10:26 am Purchase | 13G | ANNEXON INC ANNX | BIOTECHNOLOGY VALUE FUND L P | 7,000,000 8.9% | 3,219,306 (+85.15%) | View |
| 2024-02-13 7:23 pm Purchase | 13G | ANNEXON INC ANNX | Logos Global Management LP | 6,944,444 8.3% | 3,844,444 (+124.01%) | View |
| 2024-02-13 6:57 pm Purchase | 13G | ANNEXON INC ANNX | Bain Capital Life Sciences Fund L.P. | 8,061,719 11% | 5,121,092 (+174.15%) | View |
| 2024-02-12 4:24 pm Purchase | 13G | ANNEXON INC ANNX | Point72 Asset Management L.P. | 4,868,603 6.2% | 4,868,603 (New Position) | View |
| 2024-02-07 07:02 am Purchase | 13G | ANNEXON INC ANNX | ADAGE CAPITAL PARTNERS GP L.L.C. | 5,645,761 7.15% | 1,450,000 (+34.56%) | View |
| 2024-01-10 08:53 am Purchase | 13G | ANNEXON INC ANNX | FMR LLC | 9,685,401 12.373% | 8,345,374 (+622.78%) | View |
| 2023-08-08 08:36 am Sale | 13G | ANNEXON INC ANNX | FEDERATED HERMES INC. FHI | 2,342,715 4.41% | -715,085 (-23.39%) | View |
| 2023-06-22 1:25 pm Purchase | 13G | ANNEXON INC ANNX | Logos Global Management LP | 3,100,000 5.8% | 3,100,000 (New Position) | View |
| 2023-05-30 5:00 pm Sale | 13G | ANNEXON INC ANNX | Bain Capital Life Sciences Fund L.P. | 2,940,627 5.5% | -1,945,989 (-39.82%) | View |
| 2023-02-27 4:02 pm Purchase | 13G | ANNEXON INC ANNX | CITADEL ADVISORS LLC | 2,500,307 5.2% | 1,018,285 (+68.71%) | View |
| 2023-02-17 4:00 pm Purchase | 13D | ANNEXON INC ANNX | Satter Muneer A | 7,679,521 15% | 2,647,058 (+52.60%) | View |
| 2023-02-14 4:18 pm Purchase | 13G | ANNEXON INC ANNX | Redmile Group LLC | 4,897,575 9.9% | 5,882 (+0.12%) | View |
| 2023-02-14 4:07 pm Purchase | 13G | ANNEXON INC ANNX | Venrock Healthcare Capital Partners II L.P. | 4,929,000 9.99% | 3,000,523 (+155.59%) | View |
| 2023-02-14 3:45 pm Purchase | 13G | ANNEXON INC ANNX | Fairmount Funds Management LLC | 3,681,456 7.7% | 1,112,056 (+43.28%) | View |